Dorton Katina insider trades
Dorton Katina has filed 21 Form 4s with the SEC that we hold, for CIK 1567892 (Director), Fulcrum Therapeutics, Inc. (FULC) (Director), TScan Therapeutics, Inc. (TCRX) (Director) and Prelude Therapeutics Inc (PRLD) (Director), among 5 companies in all. None of these filings reports a purchase (code P) or sale (code S) of common stock; they cover grants, option exercises and other codes. The first filing on our record is dated 2022-05-03 and the latest 2026-07-17.
CIK 1567892
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Fulcrum Therapeutics, Inc. (FULC)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
TScan Therapeutics, Inc. (TCRX)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Prelude Therapeutics Inc (PRLD)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
ECOL
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1617541) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms